QT PRODACT: Inter-facility variability in electrocardiographic and hemodynamic parameters in conscious dogs and monkeys

被引:21
作者
Sasaki, H [1 ]
Shimizu, N
Suganami, H
Yamamoto, K
机构
[1] JPMA, QT PRODACT, Tokyo 1030023, Japan
[2] Fuji Biomedix Co Ltd, Kobuchisawa Labs, Yamanashi 4080044, Japan
[3] Kowa Co Ltd, Biostat & Data Management Dept, Tokyo 1038433, Japan
[4] Takeda Pharmaceut Co Ltd, Dev Res Ctr, Osaka 5328686, Japan
关键词
conscious dog; conscious monkey; QTc interval; inter-facility variability; dl-sotalol;
D O I
10.1254/jphs.QT-B6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In safety pharmacology studies, the effect of a test compound on the electrocardiogram is routinely examined by using conscious dogs. However, the results may be widely variable. The monkey, on the other hand, has scarcely been used for such studies; and as yet, there have not been reported studies on monkeys conducted at several facilities with a standard protocol. In the present study, we examined inter-facility variabilities in electrocardiographic and hemodynamic parameters as described below. We analyzed the data from 8 facilities (9 test groups) on dogs and 5 facilities (7 test groups) on monkeys. This data was obtained from the studies employing the following standard protocol: dl-Sotalol or a vehicle (0.5 w/v% methylcellulose solution) was given to animals; and the PR interval, QRS duration, QT interval, heart rate, and mean blood pressure were determined time-sequentially before and after administration of the vehicle or dl-sotalol in each test group. dl-Sotalol produced a prolongation of the maximum mean QTcF interval in conscious dogs and QTcB interval in conscious monkeys by more than 10% in every test group. No difference in the corrected QT interval among the test groups was observed in dogs, but a difference was observed in monkeys.
引用
收藏
页码:513 / 522
页数:10
相关论文
共 61 条
[1]  
Ackerman M J, 1998, Pediatr Rev, V19, P232, DOI 10.1542/pir.19-7-232
[2]   INFLUENCE OF HEART-RATE AND INHIBITION OF AUTONOMIC TONE ON THE QT INTERVAL [J].
AHNVE, S ;
VALLIN, H .
CIRCULATION, 1982, 65 (03) :435-439
[3]   QT PRODACT: In vivo QT assay with a conscious monkey for assessment of the potential for drug-induced QT interval prolongation [J].
Ando, K ;
Hombo, T ;
Kanno, A ;
Ikeda, H ;
Imaizumi, M ;
Shimizu, N ;
Sakamoto, K ;
Kitani, S ;
Yamamoto, Y ;
Hizume, S ;
Nakai, K ;
Kitayama, T ;
Yamamoto, K .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 99 (05) :487-500
[4]  
ANTONACCIO MJ, 1990, AM J CARDIOL, V65, pA12
[5]  
ANTTILA M, 1976, ACTA PHARMACOL TOX, V39, P118
[6]   A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs [J].
Batey, AJ ;
Doe, CPA .
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS, 2002, 48 (01) :11-19
[7]  
BEXTON RS, 1986, BRIT HEART J, V55, P253
[8]   PROLONGATION OF THE Q-T INTERVAL IN MAN DURING SLEEP [J].
BROWNE, KF ;
PRYSTOWSKY, E ;
HEGER, JJ ;
CHILSON, DA ;
ZIPES, DP .
AMERICAN JOURNAL OF CARDIOLOGY, 1983, 52 (01) :55-59
[9]   MODULATION OF THE Q-T INTERVAL BY THE AUTONOMIC NERVOUS-SYSTEM [J].
BROWNE, KF ;
PRYSTOWSKY, E ;
HEGER, JJ ;
ZIPES, DP .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1983, 6 (05) :1050-1056
[10]  
Carlsson L, 2001, EUR HEART J SUPPL, V3, pK114, DOI 10.1016/S1520-765X(01)90016-1